Caris Life Sciences vs LabGenius Therapeutics
Caris Life Sciences vs LabGenius Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and LabGenius Therapeutics on 61/100.
Where each one leads
Caris Life Sciences
- domain rating: 63/100 against 46/100
- funding raised: $700M against $3.0M
LabGenius Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | LabGenius Therapeutics |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | AI-driven drug discovery platform for rapid development of novel therapeutics. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, AI-Driven Protein Design, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2019 |
| Headquarters | Irving, United States | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | LabGenius Therapeutics |
|---|---|---|
| Employees | 1,659 | Not published |
| Total funding | $700M | $3.0M |
| Latest round | Series D | Seed |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | LabGenius Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 61/100 |
| Traction | 60/100 | Not published |
| Team | Not published | 36/100 |
| Search visibility | 22/100 | Not published |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | LabGenius Therapeutics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Caris Life Sciences vs LabGenius Therapeutics: common questions
Which is better, Caris Life Sciences or LabGenius Therapeutics?
On our 0-100 score LabGenius Therapeutics rates higher (61/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and LabGenius Therapeutics compare on the numbers?
Caris Life Sciences leads on domain rating (63/100 against 46/100), funding raised ($700M against $3.0M).
Read the full Caris Life Sciences review and pricing or the LabGenius Therapeutics review and pricing. You can also browse other Caris Life Sciences alternatives we track.